NCT06060782
- Conditions
- Acute Lymphoblastic Leukemia, Adult, Burkitt Lymphoma, DNA Virus Infections, +20 more
- Locations
-
- The Fifth Affiliated Hospital of Sun Yat-sen University Zhuhai, Guangdong, China
Clinical trial condition
Burkitt Lymphoma
Explore clinical trials studying Burkitt Lymphoma. Study availability and eligibility vary by location and protocol.
58 public trials
23 recruiting studies
Burkitt Lymphoma trial results
Recruiting
Immunotherapy in Lymphoma
NCT06796517
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Diffuse Large B Cell Lymphoma Relapsed, +22 more
- Locations
-
- Seoul St. Mary Hospital Seoul, South Korea
- Yeoido St. Mary Hospital Seoul, South Korea
NCT05518383
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Diffuse Large B-cell Lymphoma, +19 more
- Locations
-
- Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology and Immunology Moscow, RF, Russia
Not Yet Recruiting
Novel Bispecific AbTCR (Anti-CD19/CD22)-T Cells in Relapsed or Refractory B-cell Lymphoma
NCT07168291
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Diffuse Large B Cell Lymphoma (DLBCL), +18 more
- Locations
-
- First Affiliated Hospital of Xi'an Jiaotong University Xi'an, Shaanxi, China
NCT05653271
- Conditions
- B-cell Lymphoma, Burkitt Lymphoma, DLBCL, +23 more
- Locations
-
- AdventHealth Orlando Orlando, Florida, United States
- Emory University Atlanta, Georgia, United States
- Indiana University Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
- Norton Cancer Institute Louisville, Kentucky, United States
Completed
ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies
NCT02362035
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, CLL, +47 more
- Locations
-
- Research Site Tucson, Arizona, United States
- Research Site Los Angeles, California, United States
- Research Site Denver, Colorado, United States
- Research Site Washington D.C., District of Columbia, United States
NCT04488354
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +47 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- University of California at San Diego San Diego, California, United States
- University of Chicago Chicago, Illinois, United States
- Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States
Completed
Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies
NCT04191187
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Biphenotypic Acute Leukemia, +56 more
- Locations
-
- H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
NCT02996773
- Conditions
- Actinomycetales Infections, Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, +52 more
- Locations
-
- The University of Arizona Cancer Center Tucson, Arizona, United States
NCT00001337
- Conditions
- Anaplastic Large-Cell Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +21 more
- Locations
-
- Holy Cross Hospital, Fort Lauderdale Fort Lauderdale, Florida, United States
- University of Maryland, Baltimore Baltimore, Maryland, United States
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
- Brigham and Women's Hospital Boston, Massachusetts, United States